论文信息 - RSV(P): Will It Be Joining Us this Fall? Interim Guidance from the AAP for the Use of Pavalizumab Prophylaxis During the Delayed RSV Surge - 字舞流文

RSV(P): Will It Be Joining Us this Fall? Interim Guidance from the AAP for the Use of Pavalizumab Prophylaxis During the Delayed RSV Surge

Melanie Wielicka

[1] J. Avner,et al. Delayed Seasonal RSV Surge Observed During the COVID-19 Pandemic , 2021, Pediatrics.

[2] N. Chiu,et al. Impact of Wearing Masks, Hand Hygiene, and Social Distancing on Influenza, Enterovirus, and All-Cause Pneumonia During the Coronavirus Pandemic: Retrospective National Epidemiological Surveillance Study , 2020, Journal of medical Internet research.

[3] E. Simões,et al. Effectiveness of Palivizumab in High-risk Infants and Children , 2017, The Pediatric infectious disease journal.

[4] RSV Policy Statement —Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection. Pediatrics 2014;134(2):415–420 , 2014, Pediatrics.

[5] Eneida A. Mendonça,et al. Updated Guidance for Palivizumab Prophylaxis Among Infants and Young Children at Increased Risk of Hospitalization for Respiratory Syncytial Virus Infection , 2014, Pediatrics.